Santhera Pharmaceuticals Holding has exclusively granted the rights to commercialise its Duchenne muscular dystrophy drug vamorolone in North America to Catalyst Pharmaceuticals...
The new article highlights the aspects related to cybersecurity for software-based medical devices intended to be marketed and used in the UK. Table of...
The new article highlights the aspects related to cybersecurity for software-based medical devices intended to be marketed and used in the UK. Table of...
The High Value Manufacturing Catapult has appointed four new non-executive directors to its board.
With extensive experience shaping transformation across the manufacturing and technology sector,...
Lots of psychedelic compounds are currently under testing to assess their benefits for treating different psychological issues. Though magic mushrooms, LSD, and ketamine get the most attention, there are many more to consider. Recently, Phase I ended for Small Pharma’s DMT trials into depression, and the results so far are very promising. Phase I DMT […]
